<?xml version="1.0" encoding="UTF-8"?>
<p>The diagnosis and treatment program for COVID-19 was formulated by NHC of China [
 <xref rid="B69-ijerph-17-05904" ref-type="bibr">69</xref>,
 <xref rid="B74-ijerph-17-05904" ref-type="bibr">74</xref>] and was previously suggested by WHO for SARS and MERS [
 <xref rid="B75-ijerph-17-05904" ref-type="bibr">75</xref>,
 <xref rid="B76-ijerph-17-05904" ref-type="bibr">76</xref>,
 <xref rid="B77-ijerph-17-05904" ref-type="bibr">77</xref>,
 <xref rid="B78-ijerph-17-05904" ref-type="bibr">78</xref>]. The specific diagnostic measures have been implemented for suspected as well as confirmed cases: a patient with a minimum of two clinical symptoms and at least one exposure history is accounted as a suspected case. The suspected case should show at least three clinical symptoms if there is not any clear exposure history.
</p>
